Amryt Pharma (AMYT) Stock Analysis

What Amryt Pharma does

Amryt Pharma plc is a commercial-stage biopharmaceutical company committed to enhancing the lives of individuals with rare and orphan diseases. The firm achieves this by acquiring, developing, and bringing to market specialized therapies. Among its current offerings, Amryt provides: Metreleptin, prescribed as a dietary adjunct and replacement therapy, addresses complications arising from leptin deficiency in patients with congenital or acquired generalized lipodystrophy. Oral octreotide serves as a long-term maintenance solution for those with acromegaly. Lomitapide, used in conjunction with a low-fat diet and other lipid-lowering medications, aids adults diagnosed with Homozygous familial Hypercholesteraemia. Its pipeline features promising investigational therapies, including Oleogel-S10, which targets the skin manifestations of Junctional and Dystrophic Epidermolysis Bullosa (EB)—a severe and uncommon genetic skin disorder impacting both children and adults. Additionally, AP103 is a pre-clinical gene therapy under development for dystrophic EB. Amryt's products are distributed across the Americas, Europe, and the Middle East. Established in 2015, Amryt Pharma plc maintains its headquarters in Dublin, Ireland.

Key metrics

ETFs linked to AMYT

Broad-market and Healthcare sector ETFs an investor holding Amryt Pharma is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how AMYT fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for Amryt Pharma?

Amryt Pharma trades under the ticker AMYT on NASDAQ.

Which exchange is AMYT listed on?

AMYT is listed on NASDAQ.

What sector does Amryt Pharma operate in?

Amryt Pharma is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

How can PortView help analyze AMYT in a portfolio?

PortView shows AMYT's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.